vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and INDEPENDENCE REALTY TRUST, INC. (IRT). Click either name above to swap in a different company.

INDEPENDENCE REALTY TRUST, INC. is the larger business by last-quarter revenue ($165.3M vs $85.1M, roughly 1.9× 4D Molecular Therapeutics, Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 2.5%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 2.2%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.

FDMT vs IRT — Head-to-Head

Bigger by revenue
IRT
IRT
1.9× larger
IRT
$165.3M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508897.5% gap
FDMT
8508900.0%
2.5%
IRT
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
2.2%
IRT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FDMT
FDMT
IRT
IRT
Revenue
$85.1M
$165.3M
Net Profit
$19.4M
Gross Margin
Operating Margin
17.3%
Net Margin
22.8%
Revenue YoY
8508900.0%
2.5%
Net Profit YoY
139.1%
EPS (diluted)
$0.43
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
IRT
IRT
Q1 26
$165.3M
Q4 25
$85.1M
$167.1M
Q3 25
$90.0K
$167.1M
Q2 25
$15.0K
$162.2M
Q1 25
$14.0K
$161.2M
Q4 24
$1.0K
$161.0M
Q3 24
$3.0K
$160.1M
Q2 24
$5.0K
$158.4M
Net Profit
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
$19.4M
$33.3M
Q3 25
$-56.9M
$6.9M
Q2 25
$-54.7M
$8.0M
Q1 25
$-48.0M
$8.4M
Q4 24
$-1.0M
Q3 24
$-43.8M
$12.4M
Q2 24
$-35.0M
$10.4M
Operating Margin
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
17.3%
Q3 25
-67983.3%
Q2 25
-396373.3%
Q1 25
-383007.1%
Q4 24
Q3 24
-1704400.0%
Q2 24
-849120.0%
Net Margin
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
22.8%
19.9%
Q3 25
-63195.6%
4.1%
Q2 25
-364386.7%
5.0%
Q1 25
-342657.1%
5.2%
Q4 24
-0.6%
Q3 24
-1461433.3%
7.7%
Q2 24
-699060.0%
6.5%
EPS (diluted)
FDMT
FDMT
IRT
IRT
Q1 26
$0.00
Q4 25
$0.43
$0.14
Q3 25
$-1.01
$0.03
Q2 25
$-0.98
$0.03
Q1 25
$-0.86
$0.04
Q4 24
$-0.01
Q3 24
$-0.79
$0.05
Q2 24
$-0.63
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
IRT
IRT
Cash + ST InvestmentsLiquidity on hand
$402.7M
$23.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$505.7M
$3.4B
Total Assets
$566.7M
$6.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
IRT
IRT
Q1 26
$23.3M
Q4 25
$402.7M
$23.6M
Q3 25
$305.1M
$23.3M
Q2 25
$293.2M
$19.5M
Q1 25
$321.4M
$29.1M
Q4 24
$424.9M
$21.2M
Q3 24
$501.9M
$17.6M
Q2 24
$541.9M
$21.0M
Total Debt
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
$2.3B
Q3 25
$2.3B
Q2 25
$2.2B
Q1 25
$2.3B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.3B
Stockholders' Equity
FDMT
FDMT
IRT
IRT
Q1 26
$3.4B
Q4 25
$505.7M
$3.5B
Q3 25
$369.0M
$3.5B
Q2 25
$420.9M
$3.4B
Q1 25
$469.7M
$3.5B
Q4 24
$510.6M
$3.4B
Q3 24
$552.9M
$3.4B
Q2 24
$588.3M
$3.4B
Total Assets
FDMT
FDMT
IRT
IRT
Q1 26
$6.1B
Q4 25
$566.7M
$6.0B
Q3 25
$424.0M
$6.1B
Q2 25
$473.6M
$6.0B
Q1 25
$515.7M
$6.0B
Q4 24
$560.4M
$6.1B
Q3 24
$604.0M
$5.9B
Q2 24
$620.1M
$5.9B
Debt / Equity
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
0.66×
Q3 25
0.66×
Q2 25
0.66×
Q1 25
0.65×
Q4 24
0.68×
Q3 24
0.68×
Q2 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
IRT
IRT
Operating Cash FlowLast quarter
$28.6M
Free Cash FlowOCF − Capex
$28.5M
FCF MarginFCF / Revenue
33.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
$28.6M
$282.1M
Q3 25
$-46.5M
$79.3M
Q2 25
$-43.4M
$82.2M
Q1 25
$-47.8M
$60.4M
Q4 24
$-134.6M
$259.8M
Q3 24
$-29.4M
$69.2M
Q2 24
$-30.2M
$83.0M
Free Cash Flow
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
$28.5M
Q3 25
$-46.6M
Q2 25
$-43.4M
Q1 25
$-48.4M
Q4 24
$-138.4M
Q3 24
$-31.2M
Q2 24
$-30.6M
FCF Margin
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
33.5%
Q3 25
-51765.6%
Q2 25
-289620.0%
Q1 25
-345635.7%
Q4 24
-13837100.0%
Q3 24
-1038966.7%
Q2 24
-611840.0%
Capex Intensity
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
0.1%
Q3 25
101.1%
Q2 25
440.0%
Q1 25
4507.1%
Q4 24
378600.0%
Q3 24
59266.7%
Q2 24
6980.0%
Cash Conversion
FDMT
FDMT
IRT
IRT
Q1 26
Q4 25
1.47×
8.48×
Q3 25
11.51×
Q2 25
10.22×
Q1 25
7.23×
Q4 24
Q3 24
5.60×
Q2 24
8.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FDMT
FDMT

Segment breakdown not available.

IRT
IRT

Rental and other property revenue$165.2M100%
Other revenue$109.0K0%

Related Comparisons